Literature DB >> 11997495

Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis.

Michela Marani1, Tencho Tenev, David Hancock, Julian Downward, Nicholas R Lemoine.   

Abstract

Bim (Bcl-2-interacting mediator of cell death) is a member of the BH3 domain-only subgroup of Bcl-2 family members, for which three splice variants have been described. Bim is expressed in many healthy cell types, where it is maintained in an inactive conformation through binding to the microtubule-associated dynein motor complex. Upon certain apoptotic stimuli, Bim is released from microtubules and mediates caspase-dependent apoptosis through a mechanism that is still unclear. Here, we have identified and characterized novel splice variants of human Bim mRNA. In particular, we show that a newly discovered, small protein isoform, BimAD, is also able to induce apoptosis strongly in several human cell lines. BimAD and the previously characterized isoform BimS are shown to be capable of heterodimerizing in vivo with both death antagonists (Bcl-2 and Bcl-X(L)) and death agonists (Bax). Mutants of BimAD that bind to Bax but not to Bcl-2 still promote apoptosis, indicating that Bim can regulate apoptosis through direct activation of the Bax-mediated cell death pathway without interaction with antiapoptotic Bcl-2 family members. Furthermore, we have shown that the interaction of the BimS and BimAD isoforms with Bax leads to a conformational change in this protein analogous to that triggered by the BH3-only protein Bid.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997495      PMCID: PMC133811          DOI: 10.1128/MCB.22.11.3577-3589.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  Structure of Bax: coregulation of dimer formation and intracellular localization.

Authors:  M Suzuki; R J Youle; N Tjandra
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

2.  MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain.

Authors:  J Bae; C P Leo; S Y Hsu; A J Hsueh
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

3.  Neuron-specific Bcl-2 homology 3 domain-only splice variant of Bak is anti-apoptotic in neurons, but pro-apoptotic in non-neuronal cells.

Authors:  Y F Sun; L Y Yu; M Saarma; T Timmusk; U Arumae
Journal:  J Biol Chem       Date:  2001-01-29       Impact factor: 5.157

Review 4.  Life-or-death decisions by the Bcl-2 protein family.

Authors:  J M Adams; S Cory
Journal:  Trends Biochem Sci       Date:  2001-01       Impact factor: 13.807

5.  Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.

Authors:  M C Wei; W X Zong; E H Cheng; T Lindsten; V Panoutsakopoulou; A J Ross; K A Roth; G R MacGregor; C B Thompson; S J Korsmeyer
Journal:  Science       Date:  2001-04-27       Impact factor: 47.728

6.  Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis.

Authors:  G V Putcha; K L Moulder; J P Golden; P Bouillet; J A Adams; A Strasser; E M Johnson
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

7.  Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1.

Authors:  P F Dijkers; R H Medema; J W Lammers; L Koenderman; P J Coffer
Journal:  Curr Biol       Date:  2000-10-05       Impact factor: 10.834

8.  tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c.

Authors:  M C Wei; T Lindsten; V K Mootha; S Weiler; A Gross; M Ashiya; C B Thompson; S J Korsmeyer
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

9.  Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim.

Authors:  P Bouillet; L C Zhang; D C Huang; G C Webb; C D Bottema; P Shore; H J Eyre; G R Sutherland; J M Adams
Journal:  Mamm Genome       Date:  2001-02       Impact factor: 2.957

10.  TNF-alpha signals apoptosis through a bid-dependent conformational change in Bax that is inhibited by E1B 19K.

Authors:  D Perez; E White
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

View more
  78 in total

Review 1.  TRAIL, Bim, and thymic-negative selection.

Authors:  Shi-Jun Zheng; Youhai H Chen
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Gene transfer: Bax to the future for cancer therapy.

Authors:  N R Lemoine; I A McNeish
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

3.  Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo.

Authors:  C Clybouw; D Merino; T Nebl; F Masson; M Robati; L O'Reilly; A Hübner; R J Davis; A Strasser; P Bouillet
Journal:  Cell Death Differ       Date:  2012-01-13       Impact factor: 15.828

4.  Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL.

Authors:  Shaohui Wang; Zhao Zhong Chong; Yan Chen Shang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2012-02       Impact factor: 1.990

5.  Natural diterpenoid compound elevates expression of Bim protein, which interacts with antiapoptotic protein Bcl-2, converting it to proapoptotic Bax-like molecule.

Authors:  Lixia Zhao; Feng He; Haiyang Liu; Yushan Zhu; Weili Tian; Ping Gao; Hongping He; Wen Yue; Xiaobo Lei; Biyun Ni; Xiaohui Wang; Haijing Jin; Xiaojiang Hao; Jialing Lin; Quan Chen
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

6.  Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity.

Authors:  Hisashi Harada; Bonnie Quearry; Antonio Ruiz-Vela; Stanley J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-14       Impact factor: 11.205

7.  Pharmacological manipulation of Bcl-2 family members to control cell death.

Authors:  Anthony Letai
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

8.  Modeling of the role of a Bax-activation switch in the mitochondrial apoptosis decision.

Authors:  Chun Chen; Jun Cui; Haizhu Lu; Rui Wang; Shuai Zhang; Pingping Shen
Journal:  Biophys J       Date:  2007-03-30       Impact factor: 4.033

9.  Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.

Authors:  Victoria Del Gaizo Moore; Jennifer R Brown; Michael Certo; Tara M Love; Carl D Novina; Anthony Letai
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 10.  Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes.

Authors:  Brian Leber; Jialing Lin; David W Andrews
Journal:  Apoptosis       Date:  2007-05       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.